Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cytotherapy

Showing results (451-460 of 3,134) with videos related to

Pageof 314
Sort By:
Cytotherapy|April 28, 2007
The International Society for Cellular Therapy annual meeting comes to Sydney in 2007D M Wall, H M Prince
Cytotherapy|April 28, 2007
The use of T-cell directed cellular therapies in AustraliaD J Moss, R Khanna, M Gandhi
Cytotherapy|May 16, 2006
Manufacturing of gene-modified cytotoxic T lymphocytes for autologous cellular therapy for lymphomaL J N Cooper, L Ausubel, M Gutierrez, et al.
Cytotherapy|May 16, 2006
Ex vivo expansion of non-MHC-restricted cytotoxic effector cells as adoptive immunotherapy for myelomaJ Y Wu, M S Ernstoff, J M Hill, et al.
Cytotherapy|May 16, 2006
Adipose tissue-derived mesenchymal stem cell yield and growth characteristics are affected by the tissue-harvesting procedureM J Oedayrajsingh-Varma, S M van Ham, M Knippenberg, et al.
Cytotherapy|October 20, 2006
Animal serum-free culture conditions for isolation and expansion of multipotent mesenchymal stromal cells from human BMI Müller, S Kordowich, C Holzwarth, et al.
Cytotherapy|October 20, 2006
Banking and transplantation of umbilical cord blood in Guangzhou, ChinaJ Y Wu, C Liao, Z P Xu, et al.
Cytotherapy|October 20, 2006
In vitro expansion of Ag-specific T cells by HLA-A*0201-transfected K562 cells for immune monitoringJ Yuan, H F Gallardo, T Rasalan, et al.
Cytotherapy|October 20, 2006
Expression and role of MHC class I-related chain in myeloma cellsM Okamoto, T Inaba, N Yamada, et al.
Cytotherapy|July 26, 2005
Natural killer cell-based immunotherapeutic strategiesH-G Klingemann
Pageof 314

Showing results (451-460 of 3,134) with videos related to

Sort By:
Pageof 314
Cytotherapy|April 28, 2007
The International Society for Cellular Therapy annual meeting comes to Sydney in 2007D M Wall, H M Prince
Cytotherapy|April 28, 2007
The use of T-cell directed cellular therapies in AustraliaD J Moss, R Khanna, M Gandhi
Cytotherapy|May 16, 2006
Manufacturing of gene-modified cytotoxic T lymphocytes for autologous cellular therapy for lymphomaL J N Cooper, L Ausubel, M Gutierrez, et al.
Cytotherapy|May 16, 2006
Ex vivo expansion of non-MHC-restricted cytotoxic effector cells as adoptive immunotherapy for myelomaJ Y Wu, M S Ernstoff, J M Hill, et al.
Cytotherapy|May 16, 2006
Adipose tissue-derived mesenchymal stem cell yield and growth characteristics are affected by the tissue-harvesting procedureM J Oedayrajsingh-Varma, S M van Ham, M Knippenberg, et al.
Cytotherapy|October 20, 2006
Animal serum-free culture conditions for isolation and expansion of multipotent mesenchymal stromal cells from human BMI Müller, S Kordowich, C Holzwarth, et al.
Cytotherapy|October 20, 2006
Banking and transplantation of umbilical cord blood in Guangzhou, ChinaJ Y Wu, C Liao, Z P Xu, et al.
Cytotherapy|October 20, 2006
In vitro expansion of Ag-specific T cells by HLA-A*0201-transfected K562 cells for immune monitoringJ Yuan, H F Gallardo, T Rasalan, et al.
Cytotherapy|October 20, 2006
Expression and role of MHC class I-related chain in myeloma cellsM Okamoto, T Inaba, N Yamada, et al.
Cytotherapy|July 26, 2005
Natural killer cell-based immunotherapeutic strategiesH-G Klingemann
Pageof 314